Simon has over 15 years of experience in the drug development process, including pre-clinical pharmacology/toxicology, phase I (including first-in-human) pharmacology/PK studies and investigator-led phase II and phase III trials. His practical experience and deep scientific knowledge of the design, management and reporting of early clinical development and human pharmacology trials will help our clients optimise their trial designs to maximise the data generated